Table 3. Comparison of clinicopathologic characteristics among three molecular subtypes in OvCa.
| Variables | Cluster I (n=110) | Cluster II (n=76) | Cluster III (n=133) | P value |
|---|---|---|---|---|
| Age at diagnosis (>60) | 46(41.8%) | 38(50.0%) | 57(42.9%) | 0.500 |
| White (Race) | 95(86.4%) | 66(86.8%) | 119(89.5%) | 0.732 |
| Stage II (FIGO Stage) | 4(3.6%) | 3(3.9%) | 10(7.5%) | 0.337 |
| Stage III (FIGO Stage) | 83(75.5%) | 56(73.7%) | 108(81.2%) | 0.379 |
| Stage IV (FIGO Stage) | 21(19.1%) | 16(21.1%) | 14(10.5%) | 0.075 |
| G2 (histology grade) | 13(11.8%) | 7(9.2%) | 16(12.0%) | 0.806 |
| G3 (histology grade) | 94(85.5%) | 66(86.8%) | 115(86.5%) | 0.958 |
| 3-year survival rate | 44(40.0%) | 20(26.3%) | 61(45.9%) | 0.108 |
| 5-year survival rate | 13(11.8%) | 6(7.9%) | 21(15.8%) | 0.243 |
| Alive (Survival state) | 41(37.3%) | 27(35.5%) | 81(60.9%) | <0.001 |